Large Language Models in Medical Diagnostics: Scoping Review With Bibliometric Analysis.
Authors
Affiliations (5)
Affiliations (5)
- Department of Reproductive Medicine, Xiangya Hospital Central South University, Changsha, China.
- Clinical Research Center for Women's Reproductive Health in Hunan Province, Changsha, China.
- Xiangya School of Medicine, Central South University, Changsha, China.
- School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou, China.
- Department of Metabolism and Endocrinology, Second Xiangya Hospital of Central South University, Changsha, China.
Abstract
The integration of large language models (LLMs) into medical diagnostics has garnered substantial attention due to their potential to enhance diagnostic accuracy, streamline clinical workflows, and address health care disparities. However, the rapid evolution of LLM research necessitates a comprehensive synthesis of their applications, challenges, and future directions. This scoping review aimed to provide an overview of the current state of research regarding the use of LLMs in medical diagnostics. The study sought to answer four primary subquestions, as follows: (1) Which LLMs are commonly used? (2) How are LLMs assessed in diagnosis? (3) What is the current performance of LLMs in diagnosing diseases? (4) Which medical domains are investigating the application of LLMs? This scoping review was conducted according to the Joanna Briggs Institute Manual for Evidence Synthesis and adheres to the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews). Relevant literature was searched from the Web of Science, PubMed, Embase, IEEE Xplore, and ACM Digital Library databases from 2022 to 2025. Articles were screened and selected based on predefined inclusion and exclusion criteria. Bibliometric analysis was performed using VOSviewer to identify major research clusters and trends. Data extraction included details on LLM types, application domains, and performance metrics. The field is rapidly expanding, with a surge in publications after 2023. GPT-4 and its variants dominated research (70/95, 74% of studies), followed by GPT-3.5 (34/95, 36%). Key applications included disease classification (text or image-based), medical question answering, and diagnostic content generation. LLMs demonstrated high accuracy in specialties like radiology, psychiatry, and neurology but exhibited biases in race, gender, and cost predictions. Ethical concerns, including privacy risks and model hallucination, alongside regulatory fragmentation, were critical barriers to clinical adoption. LLMs hold transformative potential for medical diagnostics but require rigorous validation, bias mitigation, and multimodal integration to address real-world complexities. Future research should prioritize explainable artificial intelligence frameworks, specialty-specific optimization, and international regulatory harmonization to ensure equitable and safe clinical deployment.